Results 241 to 250 of about 785,669 (310)

NeoThy™ immune-humanized mice can produce anti-drug antibodies to support immunogenicity assessment for biological drug products. [PDF]

open access: yesFront Immunol
Gharaie S   +10 more
europepmc   +1 more source

In Vivo Neutralization of Hepatitis B Virus Infection by an Anti-preS1 Humanized Antibody in Chimpanzees

open access: yesVirology, 2004
Previously, we generated a murine monoclonal antibody (mAb), KR127, that recognizes amino acids (aa) 37–45 of the preS1 of hepatitis B virus (HBV).
Chun Jeih Ryu, Hyo Jeong Hong
exaly   +2 more sources
Some of the next articles are maybe not open access.

Related searches:

Humanized antibodies

Trends in Pharmacological Sciences, 1993
Hybridoma technology enabled rodent monoclonal antibodies to be created against human pathogens and cells, but these had limited clinical utility. Protein engineering, reviewed her by Greg Winter and William Harris, is now generating antibodies for treatment of infectious disease, autoimmune disease and cancer by 'humanizing' rodent antibodies ...
G, Winter, W J, Harris
openaire   +3 more sources

Human monoclonal antibodies

Molecular and Cellular Biochemistry, 1984
The technology for the production of murine monoclonal antibodies has been refined enormously since its introduction in 1975. However, the technology for generating human monoclonal antibodies has only recently come into its own. In this review, three currently available approaches to the production of human monoclonal antibodies are described.
S P, Cole   +4 more
openaire   +4 more sources

Humanized antibodies for therapy

Nature, 1991
Protein engineering has made it possible to combine the binding sites of murine antibodies with human antibody regions. Antibodies constructed in this way have important advantages for therapy.
M S, Co, C, Queen
openaire   +2 more sources

Human therapeutic antibodies

Current Opinion in Pharmacology, 2001
The development of genetic engineering technologies has today advanced to the point where the generation of high-affinity human antibodies against therapeutic targets is not a major hurdle. Rather, it is the selection of target molecules in, for example, cancer therapy that poses a challenge. Targets that are not merely passive acceptors but those that
C A, Borrebaeck, R, Carlsson
openaire   +2 more sources

Human antibodies by design

Nature Biotechnology, 1998
Monoclonal antibodies (Mabs) have long been considered a good class of natural drugs, both because they mimic their natural role in the body and because they have no inherent toxicity. Although rodent Mabs are readily generated, their widespread use as therapeutic agents has been hampered because they are recognized as foreign by the patient. Evidently,
T J, Vaughan, J K, Osbourn, P R, Tempest
openaire   +2 more sources

Human Antibody Repertoires

2008
Symplex is an antibody discovery technology that identifies fully human antigen-specific antibody repertoires directly from plasma cells. The technology utilizes reverse transcription and overlap extension polymerase chain reaction performed on single-cell-sorted plasma cells, whereby the heavy- and light-chain cognate pairing of the antibodies is ...
Per-Johan, Meijer   +3 more
openaire   +2 more sources

Antibody Humanization

Antibody humanization is the process by which animal species' antibodies (usually murine) are engineered to more closely resemble human antibodies so that they are less likely to elicit anti-drug antibody responses when used clinically. The process involves selection of human antibody acceptor templates, followed by the identification of amino acids ...
openaire   +2 more sources

Human monoclonal antibodies

Immunology Today, 1988
Abstract Reproducible and efficient production of human monoclonal antibodies of predefined specificity has proved to be a notoriously difficult task. Many variations on basic production techniques now exist and, as Keith Thompson reviews here, the comparative ease with which they can now be made promises to open up numerous new research avenues.
openaire   +2 more sources

Home - About - Disclaimer - Privacy